14 papers
Time restricted
14 publications — 6 trials, 5 syntheses.
Hva dette nettstedet er bygget på, emne for emne: hvor mange artikler, hvor mange er studier, og hvor nylige. Generert fra innhøstingen, så det kan ikke avvike fra selve sitatene.
14 papers
14 publications — 6 trials, 5 syntheses.
13 papers
13 publications — 3 trials, 7 syntheses.
12 papers
12 publications — 4 trials, 4 syntheses.
10 papers
10 publications — 2 trials, 6 syntheses.
10 papers
10 publications — 3 trials, 6 syntheses.
9 papers
9 publications — 3 trials, 5 syntheses.
9 papers
9 publications — 5 trials, 1 synthesis.
8 papers
8 publications — 3 trials, 3 syntheses.
7 papers
7 publications — 1 trial, 5 syntheses.
What the trials actually show about semaglutide, tirzepatide and the rest of the GLP-1 class.
Energy expenditure, insulin resistance and metabolic adaptation, without the folklore.
Diets, drugs, behaviour and maintenance — ranked by the strength of the evidence behind them.
Sleep, circadian rhythm and the wearables that claim to measure both.
Denne siden ble oversatt automatisk fra engelsk. Henvisningene og tallene er uendret. Les den engelske originalen hvis noe virker merkelig. Les den engelske originalen